Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has provided an update.
Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced an extraordinary general meeting scheduled for November 19, 2025, to discuss significant changes in its governance structure. The meeting will consider the abolishment of the Supervisory Committee, amendments to the Articles of Association, and changes to the rules of procedures for general and board meetings. Additionally, amendments to the working system for independent directors and management measures for the use of proceeds will be reviewed, along with the 2025 Third Quarterly Profit Distribution Plan. These proposed changes indicate a strategic shift in the company’s governance and operational procedures, potentially impacting its stakeholders and market positioning.
The most recent analyst rating on (HK:1858) stock is a Hold with a HK$17.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical instruments industry, focusing on the development and manufacturing of medical devices.
Average Trading Volume: 2,061,478
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.81B
For a thorough assessment of 1858 stock, go to TipRanks’ Stock Analysis page.